1. Catalpol from Rehmannia glutinosa Targets Nrf2/NF-κB Signaling Pathway to Improve Renal Anemia and Fibrosis.
- Author
-
Liu, Zhi-Hui, Xu, Qing-Yang, Wang, Yu, Gao, Hong-Xin, Min, Ya-Hong, Jiang, Xiao-Wen, and Yu, Wen-Hui
- Subjects
- *
ANEMIA prevention , *CHINESE medicine , *NF-kappa B , *BIOLOGICAL models , *KIDNEY function tests , *FLOW cytometry , *RESEARCH funding , *HERBAL medicine , *ENZYME-linked immunosorbent assay , *APOPTOSIS , *CELLULAR signal transduction , *TREATMENT effectiveness , *IN vivo studies , *OXIDATIVE stress , *CYTOCHEMISTRY , *FLUORESCENT antibody technique , *DESCRIPTIVE statistics , *CHRONIC kidney failure , *FIBROSIS , *MICE , *IMMUNOHISTOCHEMISTRY , *GLYCOSIDES , *ANIMAL experimentation , *WESTERN immunoblotting , *ANALYSIS of variance , *INFLAMMATION , *STAINS & staining (Microscopy) , *COMPARATIVE studies , *KIDNEYS , *NUCLEAR factor E2 related factor , *BIOMARKERS - Abstract
Rehmannia glutinosa is widely recognized as a prominent medicinal herb employed by practitioners across various generations for the purpose of fortifying kidney yin. Within Rehmannia glutinosa, the compound known as catalpol (CAT) holds significant importance as a bioactive constituent. However, the protective effects of CAT on kidneys, including ameliorative effects on chronic kidney disease — most prominently renal anemia and renal fibrosis — have not been clearly defined. In this study, the kidney injury model of NRK-52E cells and C57BL/6N male mice was prepared by exposure to aristolochic acid I (AA-I), and it was discovered that CAT could ameliorate oxidative stress injury, inflammatory injury, apoptosis, renal anemia, renal fibrosis, and other renal injuries both in vivo and in vitro. Further treatment of NRK-52E cells with Nrf2 inhibitors (ML385) and activators (ML334), as well as NF-κB inhibitors (PDTC), validated CAT's ability to target Nrf2 activation. Furthermore, the expression of phosphorylated NF-κB p65, IL-6, and Cleaved-Caspase3 protein was inhibited. CAT also inhibited NF-κB, and then inhibited the expression of IL-6, p-STAS3, TGF-β1 protein. Therefore, CAT can regulate Nrf2/NF-κB signaling pathway, significantly correct renal anemia and renal fibrosis, and is conducive to the preservation of renal structure and function, thus achieving a protective effect on the kidneys. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF